Could Radiomic Signature on Chest CT Predict Epidermal Growth Factor Receptor Mutation in Non-Small-Cell Lung Cancer?

被引:1
|
作者
Cangir, Ayten Kayi [1 ]
Koksoy, Elif Berna [2 ]
Orhan, Kaan [3 ]
Ozakinci, Hilal [4 ]
Coruh, Aysegul Gursoy [5 ]
Gumustepe, Esra [6 ]
Kahya, Yusuf [1 ]
Ibrahimov, Farrukh [1 ]
Buyukceran, Emre Utkan [5 ]
Akyurek, Serap [5 ]
Sak, Serpil Dizbay [4 ]
机构
[1] Ankara Univ, Fac Med, Med Design Applicat & Res Ctr MEDITAM, Dept Thorac Surg, TR-06070 Ankara, Turkiye
[2] Ankara Univ, Fac Med, Dept Radiol, TR-06230 Ankara, Turkiye
[3] Ankara Univ, Fac Dent, Med Design Applicat & Res Ctr MEDITAM, TR-06070 Ankara, Turkiye
[4] Ankara Univ, Fac Med, Dept Pathol, TR-06070 Ankara, Turkiye
[5] Ankara Univ, Fac Med, Dept Radiol, TR-06070 Ankara, Turkiye
[6] Gulhane Training & Res Hosp, TR-06010 Ankara, Turkiye
来源
APPLIED SCIENCES-BASEL | 2024年 / 14卷 / 20期
关键词
lung cancer; <italic>EGFR</italic> mutation; biomarkers; computed tomography; radiomics; BIOPSY; HETEROGENEITY; OSIMERTINIB;
D O I
10.3390/app14209367
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Background: Detecting molecular drivers is crucial in the management of non-small-cell lung cancer (NSCLC). This study aimed to evaluate the use of pretreatment chest computed tomography (CT) radiomics features for predicting epidermal growth factor receptor (EGFR) mutation status in NSCLC. Materials and Methods: CT images were used to develop a radiomics-based model for predicting EGFR mutation status. Two different groups were formed from the dataset, namely groups for training (n = 380) and testing (n = 86). Feature selection was performed using the Least Absolute Shrinkage and Selection Operator (LASSO) algorithm on a radiomics platform. Machine learning methods were then applied to construct the radiomics models. Receiver operating characteristic curve analysis was conducted to assess the performance of the radiomics signature across different datasets and methods. Results: The frequency of EGFR mutation was 13.5% (58/430). A total of 1409 quantitative imaging features were extracted from CT images using the Radcloud platform. Among the six radiomics-based classifiers (k-Nearest Neighbor, Support Vector Machine (SVM), eXtreme Gradient Boosting, Random Forest, Logistic Regression, and Decision Tree), SVM demonstrated the highest area under the curve values in both the testing and training groups, reaching 0.87 and 0.98, respectively. Our model, which incorporated both clinical and radiomics data, successfully predicted EGFR mutation status with an accuracy rate of 86.9%. Conclusion: Our findings highlight the potential of radiomics features as a non-invasive predictive imaging biomarker for EGFR mutation status, which could enhance personalized treatment in NSCLC. Radiomics emerges as a valuable tool for identifying driver mutations, although further studies are necessary to validate its clinical utility in NSCLC.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer
    Kotsakis, Athanasios
    Georgoulias, Vassilis
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (14) : 2363 - 2389
  • [2] Epidermal growth factor receptor inhibitors and their role in non-small-cell lung cancer
    Byrne B.J.
    Garst J.
    Current Oncology Reports, 2005, 7 (4) : 241 - 247
  • [3] Management of Brain Metastases in epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer
    Kelly, William J.
    Shah, Neil J.
    Subramaniam, Deepa S.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [4] Ideal sequencing in Stage IV epidermal growth factor receptor mutant Non-Small-Cell Lung Cancer
    Walia, Meenu
    Singhal, Manish K.
    Kamle, Mangesh S.
    INDIAN JOURNAL OF CANCER, 2022, 59 : S80 - S89
  • [5] Predictive Biomarkers to Tyrosine Kinase Inhibitors for the Epidermal Growth Factor Receptor in Non-Small-Cell Lung Cancer
    De Luca, A.
    Normanno, N.
    CURRENT DRUG TARGETS, 2010, 11 (07) : 851 - 864
  • [6] Association of radiomic features with epidermal growth factor receptor mutation status in non-small cell lung cancer and survival treated with tyrosine kinase inhibitors
    Wang, Changbin
    Dong, Xinzhe
    Sun, Xiaorong
    Zhang, Ran
    Xing, Ligang
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (11) : 1091 - 1098
  • [7] Development and Validation of Machine Learning Models to Predict Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer: A Multi-Center Retrospective Radiomics Study
    Liu, Yafeng
    Zhou, Jiawei
    Wu, Jing
    Wang, Wenyang
    Wang, Xueqin
    Guo, Jianqiang
    Wang, Qingsen
    Zhang, Xin
    Li, Danting
    Xie, Jun
    Ding, Xuansheng
    Xing, Yingru
    Hu, Dong
    CANCER CONTROL, 2022, 29
  • [8] CT characteristics of non-small cell lung cancer with epidermal growth factor receptor mutation: a systematic review and meta-analysis
    Zenghui Cheng
    Fei Shan
    Yuesong Yang
    Yuxin Shi
    Zhiyong Zhang
    BMC Medical Imaging, 17
  • [9] CT characteristics of non-small cell lung cancer with epidermal growth factor receptor mutation: a systematic review and meta-analysis
    Cheng, Zenghui
    Shan, Fei
    Yang, Yuesong
    Shi, Yuxin
    Zhang, Zhiyong
    BMC MEDICAL IMAGING, 2017, 17
  • [10] Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib
    Liu, G.
    Gurubhagavatula, S.
    Zhou, W.
    Wang, Z.
    Yeap, B. Y.
    Asomaning, K.
    Su, L.
    Heist, R.
    Lynch, T. J.
    Christiani, D. C.
    PHARMACOGENOMICS JOURNAL, 2008, 8 (02) : 129 - 138